Strengthening High-Impact Interventions for an AIDS-Free Generation (AIDSFree) Project Tanzania/Jhpiego (2016).
This report presented findings from a pilot study in Tanzania to test a nonsurgical device for medical male circumcision. Multiple studies have shown that voluntary medical male circumcision (VMMC) can prevent heterosexual HIV infection in uninfected men by up to 60 percent. Both the World Health Organization and the Joint United Nations Programme on HIV/AIDS recommend promoting male circumcision as part of a comprehensive HIV treatment package. However, given the limited financial and human resources in many developing countries, alternatives to conventional procedures for medical circumcision may help countries reach their VMMC targets. This document presents findings from the Tanzania PrePex™ Acceptability and Safety Study (TZ-PASS), implemented by the AIDSFree Project to determine the benefits, acceptability, and risks of the PrePex™ device for nonsurgical circumcision in routine clinical settings in three regions of Tanzania. This device, which accomplishes VMMC nonsurgically through a procedure that can be performed by mid-level health care providers in a nonsterile setting, may make it easier for countries to reach recommended national targets. The study examined clinical outcomes, healing time, and client and partner views on the experience of circumcision with this device, and found the PrePex™ approach safe and socially acceptable in the study regions.